You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR NORETHINDRONE AND ETHINYL ESTRADIOL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NORETHINDRONE AND ETHINYL ESTRADIOL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000897 ↗ A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and Women Completed National Institute of Allergy and Infectious Diseases (NIAID) N/A 1969-12-31 The purpose of this study is to look at the effects of different methods of birth control (oral and injectable) on how the body absorbs, makes available, and removes zidovudine (ZDV). This study will also evaluate the differences in men and women in how the body absorbs, makes available, and removes ZDV. Past research has shown that the effectiveness of ZDV as an anti-HIV drug might be decreased in individuals who use certain methods of birth control. ZDV may also have different effects in men compared to women.
NCT00004763 ↗ Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism Completed Baylor College of Medicine Phase 2 1993-01-01 OBJECTIVES: I. Evaluate the beneficial effects of leuprolide depot, oral contraceptive therapy, and leuprolide/oral contraceptive therapy in the management of patients with ovarian hyperandrogenism.
NCT00004763 ↗ Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism Completed National Center for Research Resources (NCRR) Phase 2 1993-01-01 OBJECTIVES: I. Evaluate the beneficial effects of leuprolide depot, oral contraceptive therapy, and leuprolide/oral contraceptive therapy in the management of patients with ovarian hyperandrogenism.
NCT00006133 ↗ Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus Completed University of Alabama at Birmingham N/A 2000-06-01 OBJECTIVES: I. Determine the effect of oral contraceptives containing low-dose synthetic estrogens and progestins on disease activity in premenopausal women with inactive, stable, or moderate systemic lupus erythematosus (SLE). II. Determine the effect of hormone replacement therapy with conjugated estrogens and progestins on disease activity in postmenopausal women with inactive, stable, or moderate SLE.
NCT00006133 ↗ Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus Completed National Center for Research Resources (NCRR) N/A 2000-06-01 OBJECTIVES: I. Determine the effect of oral contraceptives containing low-dose synthetic estrogens and progestins on disease activity in premenopausal women with inactive, stable, or moderate systemic lupus erythematosus (SLE). II. Determine the effect of hormone replacement therapy with conjugated estrogens and progestins on disease activity in postmenopausal women with inactive, stable, or moderate SLE.
NCT00212277 ↗ Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea. Completed Nobelpharma Phase 3 2005-02-01 The purpose of this long-term study is to determine whether combination oral contraceptive pill of Norethindrone & Ethinyl estradiol is effective in the treatmentof dysmenorrhea associated with endometriosis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NORETHINDRONE AND ETHINYL ESTRADIOL

Condition Name

Condition Name for NORETHINDRONE AND ETHINYL ESTRADIOL
Intervention Trials
Contraception 4
Dysmenorrhea 3
Healthy 3
Healthy Participants 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NORETHINDRONE AND ETHINYL ESTRADIOL
Intervention Trials
HIV Infections 3
Dysmenorrhea 3
Arthritis 2
Lupus Erythematosus, Systemic 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NORETHINDRONE AND ETHINYL ESTRADIOL

Trials by Country

Trials by Country for NORETHINDRONE AND ETHINYL ESTRADIOL
Location Trials
United States 112
Belgium 1
United Kingdom 1
Denmark 1
Spain 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NORETHINDRONE AND ETHINYL ESTRADIOL
Location Trials
California 12
Florida 10
Texas 8
Virginia 6
Pennsylvania 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NORETHINDRONE AND ETHINYL ESTRADIOL

Clinical Trial Phase

Clinical Trial Phase for NORETHINDRONE AND ETHINYL ESTRADIOL
Clinical Trial Phase Trials
Phase 4 1
Phase 3 10
Phase 2 2
[disabled in preview] 28
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NORETHINDRONE AND ETHINYL ESTRADIOL
Clinical Trial Phase Trials
Completed 29
Recruiting 3
Not yet recruiting 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NORETHINDRONE AND ETHINYL ESTRADIOL

Sponsor Name

Sponsor Name for NORETHINDRONE AND ETHINYL ESTRADIOL
Sponsor Trials
Bristol-Myers Squibb 9
GlaxoSmithKline 4
Warner Chilcott 4
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NORETHINDRONE AND ETHINYL ESTRADIOL
Sponsor Trials
Industry 36
Other 19
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.